Philip Morris International Inc. filings document the reporting obligations of a global tobacco and smoke-free products company with NYSE-listed common stock and multiple listed note series. The record includes Form 8-K material-event reports, periodic-report references, proxy materials, and exchange notices covering debt securities.
The company’s disclosures address operating results, risk factors, product and regulatory matters, capital structure, debt listings, shareholder voting, director elections, executive compensation, auditor ratification, shareholder proposals, and notices of removal from listing or registration for specified notes.
Philip Morris International reported an intended sale of 1,000 shares of Common Stock under Form 144 through UBS Financial Services Inc. The filing lists two vested restricted awards—428 shares (02/16/2022) and 572 shares (02/15/2023)—and shows a planned sale date of 02/20/2026 by wire.
Philip Morris filed a Form 144 reporting proposed sales of Common Stock by a selling holder.
The filing lists vested awards with specific share amounts and grant dates: a Vested Restricted Award of 112 shares (grant 02/15/2023), a Vested Performance Award of 2,333 shares (grant 02/15/2023), a Vested Restricted Award of 2,327 shares (grant 02/21/2024), and a Vested Performance Award of 228 shares (grant 02/21/2024). The filing references 02/20/2026 and lists Common Stock trades via wire.
Philip Morris International filed a Form 144 reporting proposed sales of common stock through UBS Financial Services Inc. on 02/20/2026. The filing lists shares tied to vested awards, including 4,035 and 6,962 share entries as examples. The entries specify vested restricted and vested performance awards as the source of the shares.
Philip Morris International reports proposed sales of vested equity awards under a Form 144. The notice lists multiple vested restricted and performance awards tied to grant dates of 02/15/2023 and 02/21/2024, with examples including 3,227 and 9,436 shares, and a broker listed as UBS Financial Services Inc.
Philip Morris International reports an intended sale of 4,000 shares of Common Stock. The form lists the broker UBS Financial Services Inc and shows settlement/transaction activity on 02/18/2026 and 02/19/2026.
The entries identify two award types that vested on 02/18/2026: a Vested Restricted Award and a Vested Performance Award, with sale movement recorded as Wire through UBS on 02/19/2026.
Philip Morris International Inc. furnished an investor presentation from the CAGNY conference, outlining its strategy to become predominantly smoke-free and its financial targets. Smoke-free products generated $16,854 million of 2025 net revenues, or 41.5% of the total $40,648 million, and contributed an increasing share of gross profit.
The company reported 2025 adjusted net revenues up 7.9% from 2024 on an organic basis and strong operating income growth, with 2020‑2025 adjusted operating income rising from $11,771 million to $16,428 million. Adjusted diluted EPS reached $7.54 in 2025, with currency-neutral growth of 14.2%.
For 2026‑2028, Philip Morris targets a 6‑8% organic net revenue CAGR, 8‑10% operating income organic CAGR, and 9‑11% currency-neutral adjusted diluted EPS CAGR, supported by high single- to low-teens volume growth in smoke-free products. The company expects about $45 billion of operating cash flow over 2026‑2028 and emphasizes ongoing dividend growth and deleveraging toward roughly 2.0x net debt to adjusted EBITDA.
Philip Morris International Inc. is presenting at the 2026 Consumer Analyst Group of New York Conference, where its CEO and CFO will discuss strategy, smoke-free products and shareholder returns, including 2026–2028 growth targets.
PMI reaffirmed its 2026 full-year reported diluted EPS forecast of $7.87 to $8.02. The company expects adjusted diluted EPS of $8.38 to $8.53, a projected increase of 11.1% to 13.1% versus $7.54 in 2025. Excluding a favorable currency impact of $0.27 per share, this implies adjusted diluted EPS of $8.11 to $8.26, or 7.5% to 9.5% growth.
PMI highlights that smoke-free products accounted for 41.5% of its full-year 2025 net revenues and estimates over 43 million adult consumers were using its smoke-free products as of December 31, 2025. The release also outlines extensive risk factors that could cause actual results to differ from these projections.
Philip Morris International Group CEO Jacek Olczak reported two equity awards. On February 5, 2026, he acquired 137,579 shares of common stock at $0, earned after the board certified achievement of the third-year performance goal for performance stock units granted on February 9, 2023. These PSUs vest on February 18, 2026.
On February 6, 2026, he received 33,460 restricted share units under the 2022 Performance Incentive Plan at a reference price of $172.93, based on the 20-day average closing price before that date. These RSUs will vest on February 21, 2029. Following these transactions, he beneficially owned 718,465 common shares, including 179,780 restricted share units, all held directly.